HuGE Literature Finder
Records
1
-
30
| Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study. Gene 2022 Oct 851 146969. Sghaier Ikram, Zidi Sabrina, El-Ghali Rabeb M, Daldoul Amira, Aimagambetova Gulzhanat, Almawi Wassim |
| Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Sep 28 (18): 4112-4120. Singer Christian F, , Holst Frederik, Steurer Stefan, Burandt Eike C, Lax Sigurd F, Jakesz Raimund, Rudas Margaretha, Stöger Herbert, Greil Richard, , Sauter Guido, Filipits Martin, , Simon Ronald, Gnant Michael, |
| Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
| Alpelisib monotherapy for PI3K-altered, pre-treated advanced breast cancer: a phase 2 study. Cancer discovery 2022 Jun . Savas Peter, Lo Louisa L, Luen Stephen J, Blackley Elizabeth F, Callahan Jason, Moodie Kate, van Geelen Courtney T, Ko Yi-An, Weng Chen-Fang, Wein Lironne, Silva Maria Joao, Zivanovic Bujak Andjelija, Yeung Miriam M, Ftouni Sarah, Hicks Rodney J, Francis Prudence A, Lee Chee Khoon, Dawson Sarah-Jane, Loi Shere |
| Bone mineral density and risk of breast cancer: A cohort study and Mendelian randomization analysis. Cancer 2022 May . Zhang Yanyu, Mao Xinhe, Yu Xingxing, Huang Xiaoxi, He Wei, Yang Haom |
| Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 May . Cristofanilli Massimo, Rugo Hope S, Im Seock-Ah, Slamon Dennis J, Harbeck Nadia, Bondarenko Igor, Masuda Norikazu, Colleoni Marco, DeMichele Angela, Loi Sherene, Iwata Hiroji, O'Leary Ben, André Fabrice, Loibl Sibylle, Bananis Eustratios, Liu Yuan, Huang Xin, Kim Sindy, Lechuga Frean Maria Jose, Turner Nicholas |
| Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR. NPJ breast cancer 2022 May 8 (1): 58. Ahn Sung Gwe, Bae Soong June, Kim Yoonjung, Ji Jung Hwan, Chu Chihhao, Kim Dooreh, Lee Janghee, Cha Yoon Jin, Lee Kyung-A, Jeong Jo |
| Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients. Biochemical genetics 2022 Feb . Allahloubi Nasr M A, Zekri Abdel-Rahman N, Ragab Mohamed, Mohanad Marwa, Ahmed Ola S, Eid Salem, Ghareeb Mohamed, Gouda Iman, Bahnassy Abeer |
| Natural History and Characteristics of ERBB2-mutated Hormone Receptor-positive Metastatic Breast Cancer: A Multi-institutional Retrospective Case-control Study from AACR Project GENIE. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Feb . LeNoue-Newton Michele L, Chen Sheau-Chiann, Stricker Thomas, Hyman David M, Blauvelt Natalie, Bedard Philippe L, Meric-Bernstam Funda, Punglia Rinaa S, Schrag Deborah, Lepisto Eva M, Andre Fabrice, Smyth Lillian, Dogan Semih, Yu Celeste, Wathoo Chetna, Levy Mia, Eli Lisa D, Xu Feng, Mann Grace, Lalani Alshad S, Ye Fei, Micheel Christine M, Arnedos Moni |
| Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer. Breast (Edinburgh, Scotland) 2022 Jan 62 52-60. Lee Soohyeon, Park Kyunghee, Kim Gun Min, Jung Kyung Hae, Kang Seok Yun, Park In Hae, Kim Jee Hyun, Ahn Hee Kyung, Park Woong-Yang, Im Seock-Ah, Park Yeon H |
| Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 2 28 (8): 1500-1506. Tolaney Sara M, Toi Masakazu, Neven Patrick, Sohn Joohyuk, Grischke Eva-Maria, Llombart-Cussac Antonio, Soliman Hatem, Wang Hong, Wijayawardana Sameera, Jansen Valerie M, Litchfield Lacey M, Sledge George |
| Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
| Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics. JCO precision oncology 2022 1 5 1297-1311. Sturgill Emma G, Misch Amanda, Lachs Rebecca, Jones Carissa C, Schlauch Dan, Jones Suzanne F, Shastry Mythili, Yardley Denise A, Burris Howard A, Spigel David R, Hamilton Erika P, McKenzie Andrew |
| Risk for relapse and death after adjuvant chemotherapy associated with SNPs in patients with breast cancer - A retrospective study. Cancer treatment and research communications 2022 30 100505. Oliva Delmy, Andersson Bengt-Åke, Nilsson Mats, Lewin Nongnit, Lewin Fred |
| TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. Cancer medicine 2021 Nov . Grote Isabel, Bartels Stephan, Kandt Leonie, Bollmann Laura, Christgen Henriette, Gronewold Malte, Raap Mieke, Lehmann Ulrich, Gluz Oleg, Nitz Ulrike, Kuemmel Sherko, Zu Eulenburg Christine, Braun Michael, Aktas Bahriye, Grischke Eva-Maria, Schumacher Claudia, Luedtke-Heckenkamp Kerstin, Kates Ronald, Wuerstlein Rachel, Graeser Monika, Harbeck Nadia, Christgen Matthias, Kreipe Ha |
| The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms. Endocrine-related cancer 2021 Oct . Venizelos Andreas, Elvebakken Hege, Perren Aurel, Nikolaienko Oleksii, Deng Wei, Lothe Inger Marie B, Couvelard Anne, Hjortland Geir Olav, Sundlöv Anna, Svensson Johanna B, Garresori Harrish, Kersten Christian, Hofsli Eva, Detlefsen Sonke, Krogh Merete, Sorbye Halfdan, Knappskog Sti |
| The rs9340799 polymorphism of the estrogen receptor alpha (ESR1) gene and its association with breast cancer susceptibility. Scientific reports 2021 Sep 11 (1): 18619. Tan Shing Cheng, Low Teck Yew, Mohamad Hanif Ezanee Azlina, Sharzehan Mohamad Ayub Khan, Kord-Varkaneh Hamed, Islam Md Asif |
| Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites. NPJ breast cancer 2021 Jul 7 (1): 93. Cha Soojin, Lee Esak, Won Hong-H |
| Genomic profile of advanced breast cancer in circulating tumour DNA. Nature communications 2021 (1): 2423. Kingston Belinda, Cutts Rosalind J, Bye Hannah, Beaney Matthew, Walsh-Crestani Giselle, Hrebien Sarah, Swift Claire, Kilburn Lucy S, Kernaghan Sarah, Moretti Laura, Wilkinson Katie, Wardley Andrew M, Macpherson Iain R, Baird Richard D, Roylance Rebecca, Reis-Filho Jorge S, Hubank Michael, Faull Iris, Banks Kimberly C, Lanman Richard B, Garcia-Murillas Isaac, Bliss Judith M, Ring Alistair, Turner Nicholas |
| Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer. Scientific reports 2021 Apr 11 (1): 8109. Hagio Kanako, Amano Toraji, Hayashi Hideyuki, Takeshita Takashi, Oshino Tomohiro, Kikuchi Junko, Ohhara Yoshihito, Yabe Ichiro, Kinoshita Ichiro, Nishihara Hiroshi, Yamashita Hiro |
| Mutation analysis using cell-free DNA for endocrine therapy in patients with HR+ metastatic breast cancer. Scientific reports 2021 Mar 11 (1): 5566. Sim Sung Hoon, Yang Han Na, Jeon Su Yeon, Lee Keun Seok, Park In H |
| Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients. Scientific reports 2021 Mar 11 (1): 6761. Muendlein Axel, Geiger Kathrin, Gaenger Stella, Dechow Tobias, Nonnenbroich Christoph, Leiherer Andreas, Drexel Heinz, Gaumann Andreas, Jagla Wolfgang, Winder Thomas, Mayer Frank, Decker Thom |
| DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysis. Annals of translational medicine 2021 Feb 9 (3): 220. Rong Guohua, Yi Zongbi, Ma Fei, Guan Yanfang, Xu Yaping, Li Lifeng, Xu Bing |
| The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival. Scientific reports 2021 Feb 11 (1): 3249. Houtsma Danny, de Groot Stefanie, Baak-Pablo Renee, Kranenbarg Elma Meershoek-Klein, Seynaeve Caroline M, van de Velde Cornelis J H, Böhringer Stefan, Kroep Judith R, Guchelaar Henk -Jan, Gelderblom Ha |
| Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy. Journal of translational medicine 2021 Jan 19 (1): 7. Kim Seongyeong, Shin Dongjin, Min Ahrum, Kim Minjung, Na Deukchae, Lee Han-Byeol, Ryu Han Suk, Yang Yaewon, Woo Go-Un, Lee Kyung-Hun, Lee Dae-Won, Kim Tae-Yong, Lee Charles, Im Seock-Ah, Kim Jong- |
| The Role of ESR1 Gene Polymorphic Markers in the Development of Breast Cancer and Resistance to Tamoxifen Therapy. Bulletin of experimental biology and medicine 2021 Jan . Lukina S S, Burdennyy A M, Zavarykina T M, Riabchikov D A, Kazubskaya T P, Kruglova M P, Loginov V |
| ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis. Frontiers in oncology 2021 11 625636. Urso Loredana, Vernaci Grazia, Carlet Jessica, Lo Mele Marcello, Fassan Matteo, Zulato Elisabetta, Faggioni Giovanni, Menichetti Alice, Di Liso Elisabetta, Griguolo Gaia, Falci Cristina, Conte Pierfranco, Indraccolo Stefano, Guarneri Valentina, Dieci Maria Vittor |
| ESR1 gene variants affect FSHR-depended risk of fibrocystic mastopathy in infertile women. Experimental oncology 2021 09 43 (3): 266-269. Kornatska A G, Rossokha Z I, Fishchuk L Ye, Dubenko O D, Medvedieva N L, Flaksemberg ? ?, Chubei G V, Popova O F, Gorovenko N |
| The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Dec . Jacob Saya, Davis Andrew A, Gerratana Lorenzo, Velimirovic Marko, Shah Ami N, Wehbe Firas, Katam Neelima, Zhang Qiang, Flaum Lisa, Siziopikou Kalliopi P, Platanias Leonidas C, Gradishar William, Behdad Amir, Bardia Aditya, Cristofanilli Massi |
| [Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients]. Molekuliarnaia biologiia 0 55 (1): 118-125. Dronova T A, Babyshkina N N, Zavyalova M V, Slonimskaya E M, Cherdyntseva N |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: